Mukul Minocha

1.7k total citations
32 papers, 612 citations indexed

About

Mukul Minocha is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mukul Minocha has authored 32 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mukul Minocha's work include Drug Transport and Resistance Mechanisms (8 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (6 papers). Mukul Minocha is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (6 papers). Mukul Minocha collaborates with scholars based in United States, Germany and United Kingdom. Mukul Minocha's co-authors include Dhananjay Pal, Varun Khurana, Ashim K. Mitra, Ashim K. Mitra, Bin Qin, Mohamed I. A. Othman, Deep Kwatra, Amit Khatri, Ahmed A. Suleiman and Sulabh Patel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mukul Minocha

31 papers receiving 597 citations

Peers

Countries citing papers authored by Mukul Minocha

Since Specialization

Citations

This map shows the geographic impact of Mukul Minocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukul Minocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukul Minocha more than expected).

Fields of papers citing papers by Mukul Minocha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mukul Minocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukul Minocha. The network helps show where Mukul Minocha may publish in the future.

Co-authorship network of co-authors of Mukul Minocha

This figure shows the co-authorship network connecting the top 25 collaborators of Mukul Minocha. A scholar is included among the top collaborators of Mukul Minocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mukul Minocha. Mukul Minocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tarlatamab Exposure–Efficacy and Exposure–Safety Relationships to Inform Dose Selection in Patients with Small Cell Lung Cancer 2025 ·Clinical Cancer Research ·(unknown), Mukul Minocha, (unknown), (unknown), Erik S. Anderson, Amanda Parkes, (unknown), Brett E. Houk, Chih‐Wei Lin	0
2	Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer 2025 ·Clinical Pharmacokinetics ·Stephanie M.Y. Kong, Mukul Minocha, Po‐Wei Chen, Pablo Martínez, Erik S. Anderson, (unknown), Brett E. Houk, Chih‐Wei Lin	3
3	PP01.72 Randomized Phase-3 Study: Tarlatamab, a DLL3-targeting Bispecific T-cell engager (BiTE), Compared to Standard-of-Care in Relapsed Small Cell Lung Cancer (DeLLphi-304) 2024 ·Journal of Thoracic Oncology ·Luis Paz-Ares Rodríguez, Enriqueta Felip, Myung‐Ju Ahn, Fiona Blackhall, Hossein Borghaei, Byoung Chul Cho, Melissa L. Johnson, Suresh S. Ramalingam, Martin Reck, Tony T. Jiang, Chia‐Hsin Ju, Mukul Minocha, Sujoy Mukherjee, Gaurav Suri, Gonzálo Recondo, Pablo Martínez	1
4	Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study 2024 ·Clinical Pharmacokinetics ·Mukul Minocha, Corbin G. Thompson, (unknown), Yanchen Zhou, Christian Brandl, (unknown), (unknown), (unknown), Pablo Martínez, Brett E. Houk	5
5	609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC) 2020 ·Annals of Oncology ·Ben Tran, Lisa G. Horvath, Tanya B. Dorff, (unknown), Martijn P. Lolkema, J-P. Machiels, Sylvie Rottey, Karen A. Autio, Richard Greil, Nabil Adra, Charlotte Lemech, Mukul Minocha, (unknown), Hosein Kouros‐Mehr, Karim Fizazi	42
6	Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus 2019 ·Clinical Pharmacokinetics ·Ahmed Nader, Mukul Minocha, Mohamed I. A. Othman	5
7	Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials 2019 ·Clinical and Translational Science ·Mukul Minocha, Hong Li, Yi‐Lin Chiu, David Carter, Mohamed I. A. Othman	10
8	Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus 2018 ·Clinical Pharmacokinetics ·Mukul Minocha, Jiewei Zeng, Jan Paul Medema, Mohamed I. A. Othman	10
9	Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials 2018 ·Clinical Pharmacokinetics ·Ahmed A. Suleiman, Amit Khatri, Mukul Minocha, Mohamed I. A. Othman	27
10	Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection 2017 ·The AAPS Journal ·Akshanth R. Polepally, Haoyu Wang, Patrick Marroum, Mukul Minocha, Balakrishna Hosmane, Amit Khatri, Sven Mensing, Thomas Podsadecki, Daniel E. Cohen, Walid M. Awni, Rajeev Menon	1
11	Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials 2015 ·Clinical Pharmacokinetics ·Mukul Minocha, Jonathan Q. Tran, James P. Sheridan, Ahmed A. Othman	8
12	Topical nanomicelles for the treatment of intermediate and posterior uveitis:Focus on micelle size 2014 ·Investigative Ophthalmology & Visual Science ·(unknown), Rakesh Chandra Vaishya, Mitan Gokulgandhi, Sulabh Patel, Mukul Minocha, Ashim K. Mitra	1
13	Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors 2014 ·Drug metabolism and drug interactions ·Varun Khurana, Mukul Minocha, Dhananjay Pal, Ashim K. Mitra	35
14	Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors 2014 ·Drug metabolism and drug interactions ·Varun Khurana, Mukul Minocha, Dhananjay Pal, Ashim K. Mitra	31
15	Drug Development and Potential Regulatory Paths for Insulin Biosimilars 2014 ·Journal of Diabetes Science and Technology ·Mukul Minocha, Jogarao Gobburu	5
16	Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib 2012 ·International Journal of Pharmaceutics ·Mukul Minocha, Varun Khurana, Bin Qin, Dhananjay Pal, Ashim K. Mitra	53
17	Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography–tandem mass spectrometry (LC/MS–MS) 2012 ·Journal of Chromatography B ·Mukul Minocha, Varun Khurana, Ashim K. Mitra	43
18	Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats 2011 ·International Journal of Pharmaceutics ·Mukul Minocha, (unknown), Deep Kwatra, Dhananjay Pal, William R. Folk, Ravinder Earla, Ashim K. Mitra	20
19	Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals 2010 ·Life Sciences ·Dhananjay Pal, Deep Kwatra, Mukul Minocha, (unknown), (unknown), Ashim K. Mitra	76
20	Interaction of Ocular Hypotensive Agents (PGF2α Analogs—Bimatoprost, Latanoprost, and Travoprost) With MDR Efflux Pumps on the Rabbit Cornea 2009 ·Journal of Ocular Pharmacology and Therapeutics ·S. Hariharan, Mukul Minocha, Gyan Prakash Mishra, Dhananjay Pal, Rohit Krishna, Ashim K. Mitra	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact